2001
DOI: 10.1053/joca.2001.0442
|View full text |Cite
|
Sign up to set email alerts
|

Effect of different growth factors on the chondrogenic potential of human bone marrow stromal cells

Abstract: We conclude that FGF2 maintains human BMSC in an immature state allowing their 'in vitro' expansion. Expanded cells retain the chondro- osteogenic potential. Interestingly, the chondrogenic potential of BMSC 'in vitro' is directly related to their ability to form bone 'in vivo'. BMSC expanded 'ex vivo' are presently being proposed for cell therapy of bone defects. 'In vitro' chondrogenesis may be regarded as a rapid prediction assay to assess cell ability to form bone after 'in vivo' transplant.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
101
1
2

Year Published

2004
2004
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 137 publications
(110 citation statements)
references
References 19 publications
6
101
1
2
Order By: Relevance
“…The best method to obtain strong cell-to-cell interaction is to culture MSCs in a pellet or micromass culture system (Johnstone et al 1998;Jones et al 2002). The bioactive factors that stimulate chondrogenesis include TGF-β1, bone morphogenic protein, fibroblast growth factor, and insulin-like growth factor (Mastrogiacomo et al 2001). TGF-β1 acts via high-affinity interaction with a heteromeric receptor complex comprising two structurally-related serine-threonine kinases, the type I and II receptors, and transduces its signals through Smad proteins intracellularly (Miyazono 2000).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The best method to obtain strong cell-to-cell interaction is to culture MSCs in a pellet or micromass culture system (Johnstone et al 1998;Jones et al 2002). The bioactive factors that stimulate chondrogenesis include TGF-β1, bone morphogenic protein, fibroblast growth factor, and insulin-like growth factor (Mastrogiacomo et al 2001). TGF-β1 acts via high-affinity interaction with a heteromeric receptor complex comprising two structurally-related serine-threonine kinases, the type I and II receptors, and transduces its signals through Smad proteins intracellularly (Miyazono 2000).…”
Section: Discussionmentioning
confidence: 99%
“…The marrow was drawn into syringes containing heparin (1,000 units) and kept on ice until later use. Bovine MSC were isolated by previously described methods (Worster et al 2000a(Worster et al , 2000bMastrogiacomo et al 2001;Holzer et al 2002;Bosnakovski et al 2004). Briefly, the bone marrow sample was washed twice with phosphate-buffered saline (PBS) and twice with Dulbecco's Modified Eagle Medium (DMEM; GIBCO BRL, Grand Islands, N.Y., USA).…”
Section: Harvesting and Isolation Of Bovine Mscmentioning
confidence: 99%
“…A large number of signaling molecules that coordinate differentiation of MSCs into chondrocytes have been extensively investigated. Basic FGF was demonstrated to increase proliferation rate and life span in rabbit, dog and human MSC while maintaining their potential to differentiate towards fat, cartilage and bone [133,134]. The family of BMPs has a pivotal role in prechondrogenic condensations and the transition of chondroprogenitor cells into chondrocytes [135][136][137].…”
Section: Vivomentioning
confidence: 99%
“…Therefore identifying expansion and differentiation conditions that promote a more chondrogenic phenotype is critical to enhancing their utility for cartilage tissue engineering applications. Differentiation conditions that have been shown to promote the chondrogenic potential of MSCs include a low oxygen (5%) microenvironment (Khan et al 2007;Buckley et al 2010a;Meyer et al 2010), various combinations of growth factors (Mastrogiacomo et al 2001;Sakimura et al 2006;Hennig et al 2007;Diekman et al 2010;Buxton et al 2011) and mechanical signals (Huang et al 2005;Mauck et al 2007;Huang et al 2010a;Huang et al 2010b;Kelly and Jacobs 2010;Li et al 2010; Thorpe et al 2010;Haugh et al 2011). …”
Section: Introductionmentioning
confidence: 99%
“…Augmenting MSC expansion conditions to enhance proliferation kinetics while maintaining multipotency is a critical obstacle to overcome in order to engineer mechanically functional tissues for clinical applications. Fibroblast growth factor-2 (FGF-2, also known as basic fibroblast growth factor) has been shown to be a potent stimulator during ex vivo expansion of both chondrocytes (Kato and Gospodarowicz 1985;Martin et al 1999;Martin et al 2001;Veilleux and Spector 2005) and MSCs (Banfi et al 2000;Mastrogiacomo et al 2001;Tsutsumi et al 2001;Bianchi et al 2003;Solchaga et al 2005;Khan et al 2008;Solchaga et al 2010), as well as regulating subsequent differentiation potential. Specifically, bone marrow derived MSCs cultured in the presence of FGF-2 have been shown to be physically smaller and proliferate more rapidly during monolayer expansion (Solchaga et al 2005).…”
Section: Introductionmentioning
confidence: 99%